AxoGen, Inc. (AXGN)
USD 16.14
(-5.28%)
USD 16.14
(-5.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 32.26 Million USD | -38.12% |
| 2022 | 52.14 Million USD | 50.28% |
| 2021 | 34.69 Million USD | 594.36% |
| 2020 | 4.99 Million USD | 115.43% |
| 2019 | -32.39 Million USD | -33.68% |
| 2018 | -24.23 Million USD | -104.2% |
| 2017 | -11.86 Million USD | -108.08% |
| 2016 | -5.7 Million USD | -1474.99% |
| 2015 | -362.08 Thousand USD | -102.15% |
| 2014 | 16.86 Million USD | 218.67% |
| 2013 | 5.29 Million USD | -31.0% |
| 2012 | 7.67 Million USD | 328.88% |
| 2011 | -3.35 Million USD | -353.35% |
| 2010 | 1.32 Million USD | 108.39% |
| 2009 | -15.76 Million USD | -4636.73% |
| 2008 | -332.84 Thousand USD | 60.04% |
| 2007 | -832.92 Thousand USD | 35.02% |
| 2006 | -1.28 Million USD | 2.2% |
| 2005 | -1.31 Million USD | 41.41% |
| 2004 | -2.23 Million USD | -1084.48% |
| 2003 | -188.84 Thousand USD | -138.26% |
| 2002 | 493.58 Thousand USD | 236.64% |
| 2001 | -361.23 Thousand USD | -145.66% |
| 2000 | 791.11 Thousand USD | 179.11% |
| 1999 | -1 Million USD | 54.55% |
| 1998 | -2.2 Million USD | -214.29% |
| 1997 | -700 Thousand USD | 12.5% |
| 1996 | -800 Thousand USD | 0.0% |
| 1995 | -800 Thousand USD | 0.0% |
| 1994 | -800 Thousand USD | -100.0% |
| 1993 | -400 Thousand USD | 73.33% |
| 1992 | -1.5 Million USD | -200.0% |
| 1991 | -500 Thousand USD | -350.0% |
| 1990 | 200 Thousand USD | 100.0% |
| 1989 | 100 Thousand USD | 133.33% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 43.84 Million USD | -7.58% |
| 2024 Q1 | 47.43 Million USD | 47.02% |
| 2023 Q1 | 59.36 Million USD | 13.85% |
| 2023 Q4 | 32.26 Million USD | -11.13% |
| 2023 Q3 | 36.3 Million USD | -17.68% |
| 2023 FY | 32.26 Million USD | -38.12% |
| 2023 Q2 | 44.1 Million USD | -25.7% |
| 2022 FY | 52.14 Million USD | 50.28% |
| 2022 Q1 | 53.43 Million USD | 54.0% |
| 2022 Q4 | 52.14 Million USD | -2.23% |
| 2022 Q3 | 53.33 Million USD | -4.52% |
| 2022 Q2 | 55.85 Million USD | 4.54% |
| 2021 Q2 | 15.13 Million USD | 4.6% |
| 2021 Q4 | 34.69 Million USD | 54.53% |
| 2021 FY | 34.69 Million USD | 594.36% |
| 2021 Q1 | 14.47 Million USD | 189.57% |
| 2021 Q3 | 22.45 Million USD | 48.34% |
| 2020 FY | 4.99 Million USD | 115.43% |
| 2020 Q1 | -32.92 Million USD | -1.63% |
| 2020 Q2 | -41.8 Million USD | -27.0% |
| 2020 Q3 | -6.71 Million USD | 83.95% |
| 2020 Q4 | 4.99 Million USD | 174.47% |
| 2019 Q1 | -18.93 Million USD | 21.84% |
| 2019 Q2 | -20.66 Million USD | -9.12% |
| 2019 Q3 | -20.78 Million USD | -0.56% |
| 2019 Q4 | -32.39 Million USD | -55.89% |
| 2019 FY | -32.39 Million USD | -33.68% |
| 2018 Q4 | -24.23 Million USD | 5.18% |
| 2018 Q3 | -25.55 Million USD | 80.85% |
| 2018 Q2 | -133.47 Million USD | -2134.16% |
| 2018 Q1 | -5.97 Million USD | 49.65% |
| 2018 FY | -24.23 Million USD | -104.2% |
| 2017 Q3 | 2.33 Million USD | 682.28% |
| 2017 FY | -11.86 Million USD | -108.08% |
| 2017 Q4 | -11.86 Million USD | -607.72% |
| 2017 Q2 | 298.76 Thousand USD | 118.24% |
| 2017 Q1 | -1.63 Million USD | 71.28% |
| 2016 Q3 | 8.99 Million USD | 34.64% |
| 2016 Q1 | 3.85 Million USD | 1164.88% |
| 2016 FY | -5.7 Million USD | -1474.99% |
| 2016 Q4 | -5.7 Million USD | -163.41% |
| 2016 Q2 | 6.67 Million USD | 73.22% |
| 2015 Q3 | -4.39 Million USD | -144.86% |
| 2015 Q2 | 9.8 Million USD | 63.03% |
| 2015 Q1 | 6.01 Million USD | -64.35% |
| 2015 FY | -362.08 Thousand USD | -102.15% |
| 2015 Q4 | -362.08 Thousand USD | 91.77% |
| 2014 FY | 16.86 Million USD | 218.67% |
| 2014 Q3 | 16.37 Million USD | 25.24% |
| 2014 Q2 | 13.07 Million USD | 38.36% |
| 2014 Q1 | 9.44 Million USD | 78.46% |
| 2014 Q4 | 16.86 Million USD | 3.05% |
| 2013 Q4 | 5.29 Million USD | 203.19% |
| 2013 Q3 | 1.74 Million USD | -88.11% |
| 2013 Q2 | 14.69 Million USD | 30.73% |
| 2013 Q1 | 11.23 Million USD | 46.46% |
| 2013 FY | 5.29 Million USD | -31.0% |
| 2012 FY | 7.67 Million USD | 328.88% |
| 2012 Q4 | 7.67 Million USD | 251.94% |
| 2012 Q3 | 2.18 Million USD | 872.49% |
| 2012 Q2 | 224.18 Thousand USD | 128.33% |
| 2012 Q1 | -791.23 Thousand USD | 76.4% |
| 2011 Q1 | -5.64 Million USD | -526.34% |
| 2011 Q2 | -9.55 Million USD | -69.38% |
| 2011 Q3 | -5.69 Million USD | 40.35% |
| 2011 Q4 | -3.35 Million USD | 41.18% |
| 2011 FY | -3.35 Million USD | -353.35% |
| 2010 Q1 | -10.17 Million USD | 35.43% |
| 2010 FY | 1.32 Million USD | 108.39% |
| 2010 Q4 | 1.32 Million USD | 114.25% |
| 2010 Q3 | -9.28 Million USD | 3.64% |
| 2010 Q2 | -9.63 Million USD | 5.36% |
| 2009 Q2 | -211.23 Thousand USD | 12.81% |
| 2009 Q3 | -227.48 Thousand USD | -7.69% |
| 2009 Q4 | -15.76 Million USD | -6830.71% |
| 2009 FY | -15.76 Million USD | -4636.73% |
| 2009 Q1 | -242.25 Thousand USD | 27.22% |
| 2008 Q2 | -588.6 Thousand USD | 27.23% |
| 2008 Q4 | -332.84 Thousand USD | 18.84% |
| 2008 Q1 | -808.87 Thousand USD | 2.89% |
| 2008 FY | -332.84 Thousand USD | 60.04% |
| 2008 Q3 | -410.1 Thousand USD | 30.33% |
| 2007 Q4 | -832.92 Thousand USD | 11.71% |
| 2007 FY | -832.92 Thousand USD | 35.02% |
| 2007 Q1 | -1.22 Million USD | 4.17% |
| 2007 Q2 | -1.05 Million USD | 14.21% |
| 2007 Q3 | -943.39 Thousand USD | 10.48% |
| 2006 Q3 | -1.36 Million USD | 5.8% |
| 2006 Q4 | -1.28 Million USD | 5.88% |
| 2006 FY | -1.28 Million USD | 2.2% |
| 2006 Q2 | -1.44 Million USD | -1.06% |
| 2006 Q1 | -1.43 Million USD | -9.15% |
| 2005 FY | -1.31 Million USD | 41.41% |
| 2005 Q2 | -1.47 Million USD | 4.69% |
| 2005 Q3 | -1.35 Million USD | 8.31% |
| 2005 Q4 | -1.31 Million USD | 3.26% |
| 2005 Q1 | -1.55 Million USD | 30.69% |
| 2004 Q2 | -602.54 Thousand USD | -36.56% |
| 2004 FY | -2.23 Million USD | -1084.48% |
| 2004 Q4 | -2.23 Million USD | -6.0% |
| 2004 Q3 | -2.11 Million USD | -250.22% |
| 2004 Q1 | -441.23 Thousand USD | -133.65% |
| 2003 FY | -188.84 Thousand USD | -138.26% |
| 2003 Q4 | -188.84 Thousand USD | -338.38% |
| 2003 Q1 | -82.89 Thousand USD | -116.79% |
| 2003 Q2 | -127.78 Thousand USD | -54.15% |
| 2003 Q3 | -43.07 Thousand USD | 66.29% |
| 2002 Q1 | 645.42 Thousand USD | 0.0% |
| 2002 Q2 | 554 Thousand USD | -14.17% |
| 2002 Q3 | 658.74 Thousand USD | 18.91% |
| 2002 Q4 | 493.58 Thousand USD | -25.07% |
| 2002 FY | 493.58 Thousand USD | 236.64% |
| 2001 Q2 | -2.47 Million USD | -299.2% |
| 2001 Q3 | -1.05 Million USD | 57.36% |
| 2001 FY | -361.23 Thousand USD | -145.66% |
| 2001 Q1 | 1.24 Million USD | 35.18% |
| 2000 Q4 | 920.54 Thousand USD | 34.06% |
| 2000 Q3 | 686.68 Thousand USD | -13.2% |
| 2000 Q2 | 791.11 Thousand USD | 110.12% |
| 2000 Q1 | 376.5 Thousand USD | 0.0% |
| 2000 FY | 791.11 Thousand USD | 179.11% |
| 1999 Q4 | - USD | 100.0% |
| 1999 Q1 | -900 Thousand USD | 10.0% |
| 1999 Q2 | -1 Million USD | -11.11% |
| 1999 Q3 | -500 Thousand USD | 50.0% |
| 1999 FY | -1 Million USD | 54.55% |
| 1998 Q3 | -2 Million USD | 9.09% |
| 1998 Q1 | -1.6 Million USD | 0.0% |
| 1998 Q2 | -2.2 Million USD | -37.5% |
| 1998 FY | -2.2 Million USD | -214.29% |
| 1998 Q4 | -1 Million USD | 50.0% |
| 1997 Q1 | -500 Thousand USD | 16.67% |
| 1997 FY | -700 Thousand USD | 12.5% |
| 1997 Q2 | -700 Thousand USD | -40.0% |
| 1997 Q3 | -600 Thousand USD | 14.29% |
| 1997 Q4 | -1.6 Million USD | -166.67% |
| 1996 FY | -800 Thousand USD | 0.0% |
| 1996 Q4 | -600 Thousand USD | -50.0% |
| 1996 Q3 | -400 Thousand USD | 50.0% |
| 1996 Q1 | -100 Thousand USD | 75.0% |
| 1996 Q2 | -800 Thousand USD | -700.0% |
| 1995 Q3 | -300 Thousand USD | 62.5% |
| 1995 Q1 | -700 Thousand USD | 12.5% |
| 1995 Q2 | -800 Thousand USD | -14.29% |
| 1995 Q4 | -400 Thousand USD | -33.33% |
| 1995 FY | -800 Thousand USD | 0.0% |
| 1994 Q2 | -800 Thousand USD | -100.0% |
| 1994 Q3 | -400 Thousand USD | 50.0% |
| 1994 FY | -800 Thousand USD | -100.0% |
| 1994 Q1 | -400 Thousand USD | -300.0% |
| 1994 Q4 | -800 Thousand USD | -100.0% |
| 1993 Q4 | -100 Thousand USD | 75.0% |
| 1993 Q2 | -400 Thousand USD | 50.0% |
| 1993 Q1 | -800 Thousand USD | -300.0% |
| 1993 FY | -400 Thousand USD | 73.33% |
| 1993 Q3 | -400 Thousand USD | 0.0% |
| 1992 FY | -1.5 Million USD | -200.0% |
| 1992 Q2 | -1.5 Million USD | -150.0% |
| 1992 Q4 | -200 Thousand USD | 50.0% |
| 1992 Q1 | -600 Thousand USD | -500.0% |
| 1992 Q3 | -400 Thousand USD | 73.33% |
| 1991 Q4 | -100 Thousand USD | 66.67% |
| 1991 FY | -500 Thousand USD | -350.0% |
| 1991 Q3 | -300 Thousand USD | 40.0% |
| 1991 Q2 | -500 Thousand USD | -266.67% |
| 1991 Q1 | 300 Thousand USD | 50.0% |
| 1990 Q2 | 200 Thousand USD | -99.57% |
| 1990 Q1 | 46 Million USD | 0.22% |
| 1990 FY | 200 Thousand USD | 100.0% |
| 1990 Q4 | 200 Thousand USD | 0.0% |
| 1990 Q3 | - USD | -100.0% |
| 1989 Q3 | 400 Thousand USD | 300.0% |
| 1989 FY | 100 Thousand USD | 133.33% |
| 1989 Q2 | 100 Thousand USD | 0.0% |
| 1989 Q4 | 45.9 Million USD | 11375.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -19.142% |
| BrainsWay Ltd. | -10.32 Million USD | 412.655% |
| Cerus Corporation | 84.35 Million USD | 61.748% |
| Envoy Medical, Inc. | -3.81 Million USD | 945.988% |
| electroCore, Inc. | -9.95 Million USD | 424.119% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 729.58% |
| IceCure Medical Ltd | -9.93 Million USD | 424.804% |
| Inogen, Inc. | -103.56 Million USD | 131.154% |
| OrthoPediatrics Corp. | -9.26 Million USD | 448.182% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 986.185% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 346.361% |
| MaxCyte, Inc. | -27.76 Million USD | 216.219% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 727.976% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 5704.003% |
| Orthofix Medical Inc. | 96.44 Million USD | 66.544% |
| PAVmed Inc | 29.08 Million USD | -10.933% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 290.483% |
| RxSight, Inc. | -6.68 Million USD | 583.024% |
| Sight Sciences, Inc. | -102.71 Million USD | 131.413% |
| SI-BONE, Inc. | 5.72 Million USD | -463.992% |
| TELA Bio, Inc. | -3.94 Million USD | 917.068% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 43.71% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -9066.477% |
| Acutus Medical, Inc. | 12.27 Million USD | -162.774% |
| Talis Biomedical Corporation | -57.06 Million USD | 156.544% |
| Spectral AI, Inc. | -3.5 Million USD | 1021.622% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 167.183% |
| CVRx, Inc. | -59.95 Million USD | 153.816% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -1526.192% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -2425.443% |
| Bioventus Inc. | 372.51 Million USD | 91.338% |
| Venus Concept Inc. | 74.3 Million USD | 56.574% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 416.893% |
| LivaNova PLC | 62.53 Million USD | 48.401% |
| 908 Devices Inc. | -115.09 Million USD | 128.034% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 89.939% |
| Nemaura Medical Inc. | 9.92 Million USD | -225.098% |
| NeuroPace, Inc. | 54.33 Million USD | 40.619% |
| LENSAR, Inc. | -18.31 Million USD | 276.201% |
| Apyx Medical Corporation | -5.15 Million USD | 726.403% |
| Cutera, Inc. | 288.3 Million USD | 88.808% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -329.355% |
| BioSig Technologies, Inc. | 262 Thousand USD | -12215.267% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 173.616% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 450.756% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 97.704% |
| Axonics, Inc. | -77.19 Million USD | 141.799% |
| Outset Medical, Inc. | 67.67 Million USD | 52.325% |
| IRIDEX Corporation | -4.28 Million USD | 852.472% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 118.125% |
| IRadimed Corporation | -47.71 Million USD | 167.616% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 1166.292% |
| INVO Bioscience, Inc. | 8.45 Million USD | -281.795% |
| Telesis Bio, Inc. | 32.63 Million USD | 1.131% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 1389.54% |
| Varex Imaging Corporation | 316.9 Million USD | 89.818% |
| Quipt Home Medical Corp. | 81.73 Million USD | 60.523% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1259.813% |
| Pulmonx Corporation | -42.36 Million USD | 176.171% |
| Dynatronics Corporation | 6.2 Million USD | -420.081% |
| Modular Medical, Inc. | -8.04 Million USD | 501.219% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 850.896% |
| Semler Scientific, Inc. | -57.13 Million USD | 156.478% |
| InMode Ltd. | -135.39 Million USD | 123.831% |
| Bruker Corporation | 891.3 Million USD | 96.38% |
| Cytosorbents Corporation | 4.18 Million USD | -671.542% |
| DexCom, Inc. | 2.02 Billion USD | 98.409% |
| Align Technology, Inc. | -840.47 Million USD | 103.839% |
| Viveve Medical, Inc. | -13.81 Million USD | 333.592% |
| ZimVie Inc. | 450.41 Million USD | 92.836% |
| Movano Inc. | -5.86 Million USD | 650.051% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 123.997% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 5704.003% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -1526.192% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 90.957% |
| Profound Medical Corp. | -18.17 Million USD | 277.495% |
| Insulet Corporation | 798.1 Million USD | 95.957% |
| enVVeno Medical Corporation | -2.21 Million USD | 1554.734% |
| Surmodics, Inc. | -12.01 Million USD | 368.57% |
| iCAD, Inc. | -21.2 Million USD | 252.134% |
| Nuwellis, Inc. | -2.81 Million USD | 1244.59% |
| Biotricity, Inc. | 23.09 Million USD | -39.724% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 65.547% |
| Aethlon Medical, Inc. | -4.5 Million USD | 816.757% |
| InspireMD, Inc. | -8.04 Million USD | 501.069% |
| PAVmed Inc. | 29.08 Million USD | -10.933% |
| BIOLASE, Inc. | 11.34 Million USD | -184.432% |
| Beyond Air, Inc. | 6.22 Million USD | -417.996% |
| FONAR Corporation | -14.66 Million USD | 320.016% |
| Vivani Medical, Inc. | 42 Thousand USD | -76723.81% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 402.74% |
| Inari Medical, Inc. | -7.16 Million USD | 550.579% |
| UFP Technologies, Inc. | 40.77 Million USD | 20.866% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -951.481% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 776.25% |
| Tenon Medical, Inc. | -1.25 Million USD | 2670.996% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 524.218% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 370.545% |
| AdaptHealth Corp. | 2.21 Billion USD | 98.545% |
| Sintx Technologies, Inc. | 905 Thousand USD | -3465.304% |
| NanoVibronix, Inc. | -3.27 Million USD | 1084.32% |
| Quanterix Corporation | -132.95 Million USD | 124.268% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1259.813% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 244.27% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 95.719% |
| TransMedics Group, Inc. | 121.13 Million USD | 73.363% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 223.247% |
| NeuroMetrix, Inc. | -1.49 Million USD | 2263.949% |
| Hyperfine, Inc. | -75.61 Million USD | 142.669% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 78.799% |
| Biomerica, Inc. | -3.38 Million USD | 1053.205% |
| Bone Biologics Corporation | -3.02 Million USD | 1166.092% |
| AVITA Medical, Inc. | -26.23 Million USD | 223.004% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 1855.103% |
| Silk Road Medical, Inc | 64.42 Million USD | 49.915% |